Leisola Matti
Laboratory of Bioprocess Engineering, Department of Chemical Technology, Helsinki University of Technology, P.O. Box 6100, 02015 TKK, Helsinki, Finland.
Adv Biochem Eng Biotechnol. 2007;107:41-56. doi: 10.1007/10_2007_052.
Biosciences and their applications, which we call biotechnology, have affected human society in many ways. Great hopes have been set on future biotechnology. The future depends on three key issues. First, we need good science. Recent developments in biosciences have surprised us in many ways. I shall explain in this article how. Secondly, we need structured innovation systems in order to commercialize our discoveries. Europe is slow in this respect compared to our Japanese and American competitors and may lose in the competition. I shall describe the Finnish innovation chain using the rewarded Otaniemi model as an example of how commercialization can be done in a systematic way. Thirdly, we need norms to guide what to do and where to go. Bioethics is probably the most neglected of the three key issues. With modern biotechnology we are able to do things that should worry every citizen, but the ethical discussion has been largely neglected or the discussion in our pluralistic society is leading nowhere. I shall finally discuss these problems from a historical perspective.
生物科学及其应用,也就是我们所说的生物技术,已经在许多方面影响了人类社会。人们对未来的生物技术寄予了厚望。未来取决于三个关键问题。首先,我们需要优秀的科学。生物科学的最新发展在许多方面让我们感到惊讶。我将在本文中解释是如何做到的。其次,我们需要结构化的创新体系,以便将我们的发现商业化。与我们的日本和美国竞争对手相比,欧洲在这方面进展缓慢,可能会在竞争中失利。我将以获奖的奥塔涅米模式为例,描述芬兰的创新链,说明如何以系统的方式实现商业化。第三,我们需要规范来指导该做什么以及走向何方。生物伦理可能是这三个关键问题中最被忽视的。借助现代生物技术,我们能够做一些应该让每个公民都担忧的事情,但伦理讨论在很大程度上被忽视了,或者说我们多元社会中的讨论没有任何结果。最后,我将从历史的角度讨论这些问题。